| Literature DB >> 28121130 |
Éva Bokor1, Sándor Kun1, David Goyard2, Marietta Tóth1, Jean-Pierre Praly2, Sébastien Vidal2, László Somsák1.
Abstract
This Review summarizes close to 500 primary publications and surveys published since 2000 about the syntheses and diverse bioactivities of C-glycopyranosyl (het)arenes. A classification of the preparative routes to these synthetic targets according to methodologies and compound categories is provided. Several of these compounds, regardless of their natural or synthetic origin, display antidiabetic properties due to enzyme inhibition (glycogen phosphorylase, protein tyrosine phosphatase 1B) or by inhibiting renal sodium-dependent glucose cotransporter 2 (SGLT2). The latter class of synthetic inhibitors, very recently approved as antihyperglycemic drugs, opens new perspectives in the pharmacological treatment of type 2 diabetes. Various compounds with the C-glycopyranosyl (het)arene motif were subjected to biological studies displaying among others antioxidant, antiviral, antibiotic, antiadhesive, cytotoxic, and glycoenzyme inhibitory effects.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28121130 DOI: 10.1021/acs.chemrev.6b00475
Source DB: PubMed Journal: Chem Rev ISSN: 0009-2665 Impact factor: 60.622